TY - JOUR
T1 - Association of serum cytokines with oral HPV clearance
AU - Lam, Jennifer O.
AU - Bream, Jay H.
AU - Sugar, Elizabeth A.
AU - Coles, Christian L.
AU - Weber, Kathleen M.
AU - Burk, Robert D.
AU - Wiley, Dorothy J.
AU - Cranston, Ross D.
AU - Reddy, Susheel
AU - Margolick, Joseph B.
AU - Strickler, Howard D.
AU - Wentz, Alicia
AU - Jacobson, Lisa
AU - Guo, Yingshi
AU - Xiao, Weihong
AU - Gillison, Maura L.
AU - D'Souza, Gypsyamber
N1 - Publisher Copyright:
© 2016 Elsevier Ltd.
PY - 2016/7/1
Y1 - 2016/7/1
N2 - Background: Initial studies suggest higher serum levels of some pro-inflammatory cytokines may be associated with decreased cervical human papillomavirus (HPV) clearance. However, the relationship of cytokines with oral HPV clearance has not been explored. Methods: From 2010 to 2014, oral rinse and serum samples were collected semi-annually from 1601 adults. Oral rinse samples were tested for HPV DNA using PCR. Based on oral HPV results, 931 serum samples were selected for cytokine evaluation to include a roughly equal number of prevalent (n = 307), incident (n = 313), and no oral HPV infections (n = 311). Electrochemiluminescence multiplex assays were used to determine the concentrations of IL-6, IL-8, TNF-α, IFN-γ, IL-1β, IL-2, IL-4, IL-10, IL-12 and IL-13. The relationship between serum cytokine concentrations (categorized into quartiles) and oral HPV clearance was evaluated with Wei-Lin-Weissfeld regression models, adjusting for HPV infection type (prevalent vs. incident), age, HIV status, and CD4 T cell count. Results: Higher TNF-α concentration was associated with decreased clearance in men (highest vs. lowest quartile, adjusted hazard ratio [aHR] = 0.52, 95% CI = 0.34-0.79) and women (aHR = 0.76, 95% confidence interval [CI] = 0.55-1.04), with stronger associations in men than women (p-interaction = 0.049). Higher IL-2 concentration was associated with reduced clearance in men (aHR = 0.69, 95% CI = 0.50-0.95), but not women (p-interaction = 0.058). Results were similar within CD4 T cell strata (CD4 ≥ 500 or CD4 < 500 cells/μl) among HIV-infected participants. No other cytokines were associated with clearance. Conclusion: High serum TNF-α is associated with reduced clearance of oral HPV infection.
AB - Background: Initial studies suggest higher serum levels of some pro-inflammatory cytokines may be associated with decreased cervical human papillomavirus (HPV) clearance. However, the relationship of cytokines with oral HPV clearance has not been explored. Methods: From 2010 to 2014, oral rinse and serum samples were collected semi-annually from 1601 adults. Oral rinse samples were tested for HPV DNA using PCR. Based on oral HPV results, 931 serum samples were selected for cytokine evaluation to include a roughly equal number of prevalent (n = 307), incident (n = 313), and no oral HPV infections (n = 311). Electrochemiluminescence multiplex assays were used to determine the concentrations of IL-6, IL-8, TNF-α, IFN-γ, IL-1β, IL-2, IL-4, IL-10, IL-12 and IL-13. The relationship between serum cytokine concentrations (categorized into quartiles) and oral HPV clearance was evaluated with Wei-Lin-Weissfeld regression models, adjusting for HPV infection type (prevalent vs. incident), age, HIV status, and CD4 T cell count. Results: Higher TNF-α concentration was associated with decreased clearance in men (highest vs. lowest quartile, adjusted hazard ratio [aHR] = 0.52, 95% CI = 0.34-0.79) and women (aHR = 0.76, 95% confidence interval [CI] = 0.55-1.04), with stronger associations in men than women (p-interaction = 0.049). Higher IL-2 concentration was associated with reduced clearance in men (aHR = 0.69, 95% CI = 0.50-0.95), but not women (p-interaction = 0.058). Results were similar within CD4 T cell strata (CD4 ≥ 500 or CD4 < 500 cells/μl) among HIV-infected participants. No other cytokines were associated with clearance. Conclusion: High serum TNF-α is associated with reduced clearance of oral HPV infection.
KW - Infection
KW - Natural history
KW - Oral HPV
KW - Persistence
KW - TNF
UR - http://www.scopus.com/inward/record.url?scp=84962752977&partnerID=8YFLogxK
U2 - 10.1016/j.cyto.2016.04.002
DO - 10.1016/j.cyto.2016.04.002
M3 - Article
C2 - 27064455
AN - SCOPUS:84962752977
SN - 1043-4666
VL - 83
SP - 85
EP - 91
JO - Cytokine
JF - Cytokine
ER -